Intravenous immunoglobulin as adjunctive therapy in kidney transplant recipients with severe pneumocystis pneumonia.

Edey, Matthew M; Gunasekera, Pumali N; Lobb, Mark; Imran, Muhammad

Edey, Matthew M; Gunasekera, Pumali N; Lobb, Mark; Imran, Muhammad.

Edey MM; Department of Nephrology, Hull University Teaching Hospitals NHS Trust, Hull, UK.
Gunasekera PN; Hull-York Medical School, Kingston-upon-Hull, UK.
Lobb M; Department of Critical Care Medicine, Hull University Teaching Hospitals NHS Trust, Hull, UK.
Imran M; Department of Transplant and Cellular Immunology, St James's University Hospital, Leeds, UK.

Transpl Infect Dis ; 23(1): e13454, 2021 Feb.

Article en En | MEDLINE | ID: mdl-32869412

Asunto(s)

Trasplante de Riñón; Neumonía por Pneumocystis; Humanos; Inmunoglobulinas Intravenosas; Pneumocystis carinii; Estudios Retrospectivos; Receptores de Trasplantes; Combinación Trimetoprim y Sulfametoxazol

Palabras clave

adjunctive therapy; intravenous immunoglobulin; life-threatening; pneumocystis pneumonia

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía por Pneumocystis / Trasplante de Riñón Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google